Article info

PDF

Concise report
Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

Authors

  1. Correspondence to Professor Arthur Kavanaugh, Division of Rheumatology, Allergy, and Immunology, School of Medicine, University of California at San Diego, La Jolla, California 92093, USA; akavanaugh{at}ucsd.edu
View Full Text

Citation

Kavanaugh A, van Vollenhoven RF, Fleischmann R, et al
Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

Publication history

  • Received 31 May 2017
  • Revised 30 October 2017
  • Accepted 3 November 2017
  • Published in print 4 December 2017.
  • Published first 16 November 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.